Replies to post #246572 on Biotech Values

[jbog]

I really don't understand you npv calculation but my back of the napkin looks like this should be paid off in a little over 7 years at a cost of <$260 mil. Assumptions are the sales will be around $85 mil this year decreasing by 10% a year. Note at 7%

Good Deal for the shareholders